Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Feugier · SciRah

Researcher profile · Semantic Scholar

P. Feugier

Share profile

P. Feugier — researcher profile on SciRah

h-index: 55
Works: 378
Citations: 14K

Most-cited papers

Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy: A DESCAR-T analysis.
R. Di Blasi, S. le Gouill, E. Bachy, G. Cartron +19 more
2022Blood162 citations Open access
Semantic Scholar
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
R. Houot, E. Bachy, G. Cartron, F. Gros +25 more
2023Nature Medicine102 citations Open access
Semantic Scholar
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
E. Parry, I. Leshchiner, R. Guièze, Connor Johnson +50 more
2023Nature Medicine79 citations Open access
Semantic Scholar
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial
L. Fornecker, J. Lazarovici, I. Aurer, R. Casasnovas +21 more
2022Journal of Clinical Oncology72 citations Open access
Semantic Scholar
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
F. Morschhauser, L. Nastoupil, P. Feugier, Jean-Marc Schiano de Colella +33 more
2022Journal of Clinical Oncology57 citations Open access
Semantic Scholar
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
E. Parry, C. Lemvigh, Stephanie L. Deng, Nathan J Dangle +31 more
2023Cancer Cell52 citations Open access
Semantic Scholar
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
O. Hermine, Linmiao Jiang, J. Walewski, A. Bosly +22 more
2022Journal of Clinical Oncology52 citations
Semantic Scholar
Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study
R. Casasnovas, R. Bouabdallah, P. Brice, J. Lazarovici +20 more
2022Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
J. Galtier, L. Vercellino, L. Chartier, P. Olivier +14 more
2022Haematologica33 citations Open access
Semantic Scholar
Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
J. Broséus, Sébastien Hergalant, Julia Vogt, E. Tausch +38 more
2023Nature Communications32 citations Open access
Semantic Scholar
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort
F. Bouclet, A. Calleja, M. Dilhuydy, L. Véronèse +22 more
2021Annals of Hematology32 citations
Semantic Scholar
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
S. Pagliuca, C. Gurnari, C. Hercus, Sébastien Hergalant +13 more
2023Nature Communications30 citations Open access
Semantic Scholar
Metabolic tumor volume predicts outcome in advanced stage follicular lymphoma patients from the Relevance trial.
A. Cottereau, L. Rebaud, J. Trotman, P. Feugier +13 more
2023Annals of Oncology28 citations Open access
Semantic Scholar
In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities.
E. ten Hacken, T. Sewastianik, Shanye Yin, Gabriela Brunsting Hoffmann +36 more
2022Blood Cancer Discovery25 citations Open access
Semantic Scholar
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL
S. Bologna, T. Borght, J. Briére, V. Ribrag +16 more
2021Hematological Oncology24 citations Open access
Semantic Scholar
Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study
J. Lazarovici, S. Amorim, K. Bouabdallah, S. Guidez +21 more
2021Blood18 citations Open access
Semantic Scholar
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
P. Sesques, R. Houot, Y. Al Tabaa, F. Le Bras +18 more
2023Blood15 citations Open access
Semantic Scholar
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
C. Rossi, M. André, J. Dupuis, F. Morschhauser +19 more
2022Haematologica15 citations Open access
Semantic Scholar
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
B. Tessoulin, D. Chiron, C. Thieblemont, L. Obéric +17 more
2021Bone Marrow Transplantation15 citations Open access
Semantic Scholar
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial
E. Hoster, M. Delfau-Larue, Elizabeth Macintyre, Linmiao Jiang +13 more
2023Journal of Clinical Oncology14 citations Open access
Semantic Scholar
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
A. Stamatoullas, H. Ghesquières, P. Feugier, M. André +13 more
2022Leukemia and Lymphoma14 citations Open access
Semantic Scholar
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
Romain Guièze, Loïc Ysebaert, Damien Roos-Weil, L. Fornecker +24 more
2024Nature Communications13 citations Open access
Semantic Scholar
Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group
R. Guièze, L. Ysebaert, D. Roos-Weil, L. Fornecker +18 more
2022Blood13 citations
Semantic Scholar
Addition of High-Dose Cytarabine to Immunochemotherapy before Autologous Stem-Cell Transplantation in Patients Aged 65 Years or Younger with Mantle Cell Lymphoma (MCL Younger): A Long-Term Follow-up of the Randomized, Open-Label, Phase 3 Trial of the European Mantle Cell Lymphoma Network
O. Hermine, Linmiao Jiang, J. Walewski, A. Bosly +11 more
2021Blood13 citations Open access
Semantic Scholar
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial
V. Camus, A. Belot, L. Obéric, D. Sibon +14 more
2022Blood Advances12 citations Open access
Semantic Scholar
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial
A. Michallet, R. Letestu, M. Le Garff-Tavernier, L. Campos +29 more
2023Blood Advances11 citations Open access
Semantic Scholar
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
C. Dartigeas, A. Quinquenel, L. Ysebaert, M. Dilhuydy +68 more
2024Annals of Hematology10 citations Open access
Semantic Scholar
Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study
R. Houot, E. Bachy, G. Cartron, F. Gros +15 more
2022Blood10 citations Open access
Semantic Scholar
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
M. Jullien, B. Tessoulin, H. Ghesquières, L. Obéric +20 more
2021Cancers9 citations Open access
Semantic Scholar
Induction and Maintenance Therapy in Elderly Patients with Mantle Cell Lymphoma: Double-Randomized MCL R2 Elderly Clinical Trial By the European Mantle Cell Lymphoma Network
V. Ribrag, V. Safar, H. Kluin-Nelemans, L. Obéric +17 more
2023Blood8 citations Open access
Semantic Scholar
Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP.
S. Bernard, H. Ghesquières, R. Casasnovas, Samuel Griolet +12 more
2021Blood Advances8 citations Open access
Semantic Scholar
Blinatumomab for Patients with Richter's Syndrome: A Multicenter Phase 2 Trial from the Filo Group
R. Guièze, L. Ysebaert, D. Roos-Weil, L. Molina +18 more
2021Blood8 citations Open access
Semantic Scholar
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
Esther Hazane Leroyer, Caroline Ziegler, Charline Moulin, A. Campidelli +4 more
2022Journal of Clinical Medicine7 citations Open access
Semantic Scholar
Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry
R. Di Blasi, S. le Gouill, E. Bachy, G. Cartron +19 more
2021Blood7 citations Open access
Semantic Scholar
Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy
S. Lamure, R. Duléry, M. Delord, R. Di Blasi +21 more
2021Oral Presentations - Proffered Abstracts7 citations
Semantic Scholar
Differential Clinical and Immunological Impacts of Anti–T‐Lymphocyte Globulin (ATLG) vs. Anti‐Thymocyte Globulin (ATG) in Preventing Graft‐Versus‐Host Disease Post‐Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative Study
A. Notarantonio, Stéphane Morisset, Romain Piucco, Michaël Pérès +17 more
2025American journal of hematology/oncology6 citations Open access
Semantic Scholar
The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge
O. Decaux, R. Garlantézec, Karim Belhadj-Merzoug, M. Macro +19 more
2024Clinical Hematology International6 citations Open access
Semantic Scholar
R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG
Gerhard Held, B. Altmann, Andrea Kerkhoff, T. Gastinne +28 more
2023Blood6 citations
Semantic Scholar
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial
A. Notarantonio, M. D'Aveni-Piney, S. Pagliuca, Yayha Ashraf +16 more
2023American journal of hematology/oncology6 citations Open access
Semantic Scholar
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)
Grégory Lazarian, M. Munger, A. Quinquenel, M. Dilhuydy +30 more
2021American journal of hematology/oncology6 citations Open access
Semantic Scholar
Prospective, Multicentric, Phase II Randomized Controlled Trial Comparing the Efficacy and Toxicity of Methotrexate to Cyclophosphamide in Large Granular Lymphocyte Leukemia: A French National Study (NCT01976182)
Thierry Lamy, C. Pastoret, G. Damaj, O. Tournilhac +13 more
2024Blood5 citations
Semantic Scholar
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group
S. Carras, Alexia Torroja, A. Emadali, E. Montaut +39 more
2023Haematologica5 citations Open access
Semantic Scholar
Age‐related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation
Alizée Jandin, C. Pochon, A. Campidelli, M. D’Aveni +10 more
2023British Journal of Haematology5 citations Open access
Semantic Scholar
Real-World Efficacy and Safety of Venetoclax Alone and in Combination with Rituximab in Patients with Chronic Lymphocytic Leukemia: Interim Results of the Verone Study
L. Ysebaert, X. Troussard, V. Lévy, R. Le Calloch +9 more
2022Blood5 citations
Semantic Scholar
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis
M. Maerevoet, O. Casasnovas, G. Cartron, F. Morschhauser +6 more
2024Cancers4 citations Open access
Semantic Scholar
Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
M. Muller, J. Broséus, A. Guilloteau, S. Wasse +17 more
2023Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
S. Pagliuca, C. Gurnari, C. Hercus, Sébastien Hergalant +13 more
2023Research Square4 citations Open access
Semantic Scholar
ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome
C. Lemvigh, E. Parry, Stephanie L. Deng, Nathan J Dangle +17 more
2022Blood4 citations
Semantic Scholar
Faculty Opinions recommendation of COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
P. Feugier, Charline Moulin
2022Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature4 citations
Semantic Scholar
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
O. Tournilhac, Solene Lecolant, M. Hacini, K. Bouabdallah +37 more
2022Blood4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Thieblemont×21
Invite
C. Thieblemont — researcher profile on SciRah
F. Morschhauser×16
Invite
F. Morschhauser — researcher profile on SciRah
G. Cartron×12
Invite
G. Cartron — researcher profile on SciRah
L. Ysebaert×11
Invite
L. Ysebaert — researcher profile on SciRah

×10

Invite

J. Broséus — researcher profile on SciRah

R. Casasnovas×10

Invite

R. Casasnovas — researcher profile on SciRah

S. le Gouill×9

Invite

S. le Gouill — researcher profile on SciRah

O. Casasnovas×9

Invite

O. Casasnovas — researcher profile on SciRah

Invite

T. Gastinne — researcher profile on SciRah

Invite

R. Guièze — researcher profile on SciRah

Invite

K. Laribi — researcher profile on SciRah

Invite

R. Houot — researcher profile on SciRah